MUC2 and rectal cancer: Intriguingly, LTD4 can also activate MUC2 via transcriptional regulation in colon adenocarcinoma [33]; nevertheless, whether pranlukast overcomes CCRT resistance through MUC2 downregulation in rectal cancer deserves further investigation.